Related Experiment Video
Updated: Apr 25, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
[Classification of Diabetic Nephropathy 2014]
Insights
The 2014 Diabetic Nephropathy classification now incorporates estimated Glomerular Filtration Rate (eGFR) for evaluating kidney function. Key changes include revised staging for chronic kidney disease (CKD) and emphasis on differential diagnosis in diabetic patients.
Area of Science:
- Nephrology
- Endocrinology
- Public Health
Context:
- The classification of diabetic nephropathy requires updates to reflect current clinical practices.
- The Research Group on Diabetic Nephropathy in Japan provided a report influencing these revisions.
- The current status of estimated Glomerular Filtration Rate (eGFR) and Chronic Kidney Disease (CKD) in Japan necessitated a review.
Purpose:
- To revise the 2014 classification of diabetic nephropathy.
- To integrate eGFR as a standard measure for Glomerular Filtration Rate (GFR) evaluation.
- To refine staging criteria for diabetic kidney disease based on recent data.
Summary:
- The revised classification allows the use of eGFR for GFR assessment.
- Stage 3 (overt nephropathy) categories A and B have been combined.
- Stage 4 (renal failure) is now defined by a GFR below 30 mL/min/1.73 m2, irrespective of albuminuria.
- The importance of differential diagnosis in all stages of diabetic nephropathy is highlighted.
Impact:
- Facilitates more accurate and consistent diagnosis of diabetic nephropathy.
- Improves patient management by standardizing CKD staging.
- Enhances clinical decision-making for healthcare professionals treating diabetic patients.
Abstract:
The Committee on Diabetic Nephropathy revised the classification of diabetic nephropathy in view of the current status of eGFR and CKD in Japan. To make revisions for the classification of diabetic nephropathy 2014, the Committee carefully evaluated the report of the Research Group on Diabetic Nephropathy, Ministry of Health, Labour, and Welfare of Japan. The major revisions made were as follows: 1. eGFR can be used for the evaluation of GFR; 2. In stage 3 (overt nephropathy), A and B were combined; 3. Stage 4 (renal failure) was defined as GFR less than 30 mL/min/1.73 m2, regardless of albuminuria; and 4. The importance of differential diagnosis was stressed in all stages.
More Related Videos
Related Concept Videos
Diabetic Nephropathy
Diabetic Retinopathy
Diabetic Neuropathy
Diabetes: Symptoms, Diagnosis, and Complications
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

